TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $437,398 | -0.5% | 28,274 | +1.0% | 0.01% | 0.0% |
| Q2 2023 | $439,612 | +25.8% | 27,983 | +32.0% | 0.01% | +18.2% |
| Q1 2023 | $349,376 | +115971.8% | 21,200 | +9.7% | 0.01% | +22.2% |
| Q4 2022 | $301 | -99.9% | 19,326 | -51.3% | 0.01% | 0.0% |
| Q3 2022 | $257,257 | +48.7% | 39,670 | +221.1% | 0.01% | +50.0% |
| Q2 2022 | $173,000 | +2.4% | 12,355 | +4.5% | 0.01% | 0.0% |
| Q1 2022 | $169,000 | +4.3% | 11,828 | -0.4% | 0.01% | 0.0% |
| Q4 2021 | $162,000 | -19.8% | 11,880 | -3.8% | 0.01% | -25.0% |
| Q3 2021 | $202,000 | -2.9% | 12,347 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $208,000 | – | 12,347 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |